Mar. 12, 2022

Molecules of the Month - February 2022

MAP855

oral MEK1/2 inhibitor Preclinical, oncology from HTS and SBDD J. Med. Chem. Novartis Institutes for BioMedical Research

twitterlinkedinprintemail